Steroid Therapy in Lymphoid Tumours
Author Information
Author(s): B. M. Groden, M. G. Dunnigan
Primary Institution: Glasgow Royal Infirmary
Hypothesis
The study aims to assess the value of steroids in producing tumour regression and subjective improvement in patients with diffuse lymphoid tumours.
Conclusion
Steroid therapy produced tumour regression in only six patients, while thirteen experienced some form of subjective improvement.
Supporting Evidence
- Six patients showed objective improvement, while seven had subjective benefit alone.
- Thirteen patients (39 percent) benefited from steroid therapy.
- Only five of the patients who improved were alive one year after starting treatment.
Takeaway
Doctors gave steroids to 34 patients with lymphoid tumours, and while some felt better, only a few had their tumours shrink.
Methodology
Patients were treated with either prednisolone or betamethasone, and responses were assessed subjectively and objectively.
Potential Biases
Placebo effects and euphoria induced by steroids may have influenced subjective improvement.
Limitations
The study could not correlate response with the dose of steroid used, and the improvement was not lasting.
Participant Demographics
Patients had diffuse lymphoid tumours and were often toxic and febrile.
Want to read the original?
Access the complete publication on the publisher's website